Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01942785
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Who this might be right for
Major Depressive DisorderIrritability
H. Lundbeck A/S 55
Post-approval studies (Phase 4)Study completedNCT00536172
What this trial is testing

Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

Who this might be right for
Depression
University of Nebraska 160
Not applicableStudy completedNCT04410575
What this trial is testing

Mental Health Assessment and Prescribing by Alberta Pharmacists

Who this might be right for
Major Depressive DisorderGeneralized Anxiety DisorderPharmacist-Patient Relations
University of Alberta 13
Large-scale testing (Phase 3)Study completedNCT00179257
What this trial is testing

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

Who this might be right for
Major Depressive Disorder
Vanderbilt University 20
Post-approval studies (Phase 4)Study completedNCT00071695
What this trial is testing

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Who this might be right for
Depression
Eli Lilly and Company 320
Not applicableLooking for participantsNCT06781593
What this trial is testing

Combining Light Therapy and CPAP in Depression

Who this might be right for
Major DepressionSleep ArchitectureObstructive Sleep Apnea+3 more
Hôpital le Vinatier 130
Very early researchWithdrawnNCT02454426
What this trial is testing

Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease

Who this might be right for
Major Depressive DisorderCoronary Artery Disease
Thomas Jefferson University
Not applicableStudy completedNCT07615387
What this trial is testing

Electrophysiological Biomarkers in Accelerated TMS for Depression

Who this might be right for
Major Depressive Disorder (MDD)
Istanbul University - Cerrahpasa 32
Large-scale testing (Phase 3)Study completedNCT00080314
What this trial is testing

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 400
Large-scale testing (Phase 3)Study completedNCT00825058
What this trial is testing

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Who this might be right for
Major Depressive Disorders
Sanofi 317
Not applicableStudy completedNCT04159285
What this trial is testing

Psychotherapeutic Augmentation of Brain Stimulation Effects

Who this might be right for
Depression ChronicDepression, UnipolarTreatment Resistant Depression
Charite University, Berlin, Germany 16
Not applicableUnknownNCT04179006
What this trial is testing

Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients

Who this might be right for
Depressive Disorder, Major
National Cheng-Kung University Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT01361555
What this trial is testing

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Who this might be right for
Depression
Bristol-Myers Squibb 789
Post-approval studies (Phase 4)Study completedNCT05465226
What this trial is testing

Oliceridine in Patients With Acute Burn Injuries

Who this might be right for
Acute PainBurnsAdverse Drug Event+2 more
University of Tennessee 31
Large-scale testing (Phase 3)Study completedNCT04285515
What this trial is testing

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Who this might be right for
Bipolar DepressionMajor Depressive Disorder
Intra-Cellular Therapies, Inc. 488
Not applicableWithdrawnNCT06328140
What this trial is testing

Sleep Quality, Cognitive Performance, and Computerized Cognitive Training

Who this might be right for
Bipolar DisorderMajor Depressive DisorderPsychosis
George West Mental Health Foundation d/b/a Skyland Trail
Testing effectiveness (Phase 2)Study completedNCT01627782
What this trial is testing

Ketamine in Patients With Treatment-resistant Depression

Who this might be right for
Major Depressive Disorder
Janssen Research & Development, LLC 68
Not applicableWithdrawnNCT01752608
What this trial is testing

Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
MindApps
Not applicableStudy completedNCT06439797
What this trial is testing

Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients

Who this might be right for
Major Depressive DisorderHealty Controls
The Chaim Sheba Medical Center 18
Large-scale testing (Phase 3)Ended earlyNCT01156415
What this trial is testing

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 837
Next Page